[
  {
    "ts": "2025-09-15T15:53:27+00:00",
    "headline": "Why California’s biopharma boom is critical for logistics",
    "summary": "Building Resilience and Innovation: California’s Pharmaceutical Renaissance California is quietly staging a pharmaceutical renaissance, not of arts or culture this time, but of science, supply chains, and life-changing therapies. As the backbone of biopharma innovation in the U.S., the Golden State is becoming a place of industry transformation, embodied most recently by investments from Amgen […] The post Why California’s biopharma boom is critical for logistics appeared first on FreightWaves.",
    "url": "https://finance.yahoo.com/news/why-california-biopharma-boom-critical-155327803.html",
    "source": "FreightWaves",
    "provider": "yfinance",
    "raw": {
      "id": "2fd9913e-e898-3d88-99e0-93543e8c1b0b",
      "content": {
        "id": "2fd9913e-e898-3d88-99e0-93543e8c1b0b",
        "contentType": "STORY",
        "title": "Why California’s biopharma boom is critical for logistics",
        "description": "",
        "summary": "Building Resilience and Innovation: California’s Pharmaceutical Renaissance California is quietly staging a pharmaceutical renaissance, not of arts or culture this time, but of science, supply chains, and life-changing therapies. As the backbone of biopharma innovation in the U.S., the Golden State is becoming a place of industry transformation, embodied most recently by investments from Amgen […] The post Why California’s biopharma boom is critical for logistics appeared first on FreightWaves.",
        "pubDate": "2025-09-15T15:53:27Z",
        "displayTime": "2025-09-15T15:53:27Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/freightwaves_373/33b9aa10449ce362d0bab12ed91ef0e8",
          "originalWidth": 2309,
          "originalHeight": 1299,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/c8JzTE.RegZ3YM3pZ8v70Q--~B/aD0xMjk5O3c9MjMwOTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/freightwaves_373/33b9aa10449ce362d0bab12ed91ef0e8.cf.webp",
              "width": 2309,
              "height": 1299,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.3qJj9PXG4NSB_8WsCwtRw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/freightwaves_373/33b9aa10449ce362d0bab12ed91ef0e8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "FreightWaves",
          "url": "https://www.freightwaves.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-california-biopharma-boom-critical-155327803.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-california-biopharma-boom-critical-155327803.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-15T13:00:02+00:00",
    "headline": "Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finance.yahoo.com/news/amgen-inc-amgn-trending-stock-130002576.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "33bed171-b06f-3746-a8a6-a122c7343d00",
      "content": {
        "id": "33bed171-b06f-3746-a8a6-a122c7343d00",
        "contentType": "STORY",
        "title": "Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It",
        "description": "",
        "summary": "Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
        "pubDate": "2025-09-15T13:00:02Z",
        "displayTime": "2025-09-15T13:00:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a",
          "originalWidth": 900,
          "originalHeight": 728,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qda7CGFBlQ8XGALeSrKgqg--~B/aD03Mjg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a.cf.webp",
              "width": 900,
              "height": 728,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4xjRGdTikgXo5SMeFUiNTA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-inc-amgn-trending-stock-130002576.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-inc-amgn-trending-stock-130002576.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-15T12:14:00+00:00",
    "headline": "Samsung Biologics, Amgen and Biocon invest in US pharma sites",
    "summary": "International drugmakers are securing domestic deals and investments as tariff pressures complicate trade and raise the cost of goods.",
    "url": "https://www.manufacturingdive.com/news/samsung-biologics-us-pharma-amgen-biocon-investment/760104/",
    "source": "Manufacturing Dive",
    "provider": "yfinance",
    "raw": {
      "id": "e5f25881-fff5-3199-870d-760af03a56cc",
      "content": {
        "id": "e5f25881-fff5-3199-870d-760af03a56cc",
        "contentType": "STORY",
        "title": "Samsung Biologics, Amgen and Biocon invest in US pharma sites",
        "description": "",
        "summary": "International drugmakers are securing domestic deals and investments as tariff pressures complicate trade and raise the cost of goods.",
        "pubDate": "2025-09-15T12:14:00Z",
        "displayTime": "2025-09-15T12:14:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/manufacturing_dive_692/f86b557aae0fa80db3edfdd32150a767",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "Contract drug manufacturer Samsung Biologics' fourth plant in Songdo, South Korea. The company recently secured a $1.3 billion supplier contract with an undisclosed U.S. pharmaceutical company.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8DNQNf7Xao9tx4ZjfdKeKw--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/manufacturing_dive_692/f86b557aae0fa80db3edfdd32150a767.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6ktPEP2v81URuPAgHMDyzg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/manufacturing_dive_692/f86b557aae0fa80db3edfdd32150a767.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Manufacturing Dive",
          "url": "https://www.manufacturingdive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.manufacturingdive.com/news/samsung-biologics-us-pharma-amgen-biocon-investment/760104/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/samsung-biologics-amgen-biocon-invest-121400928.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "207940.KS"
            },
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]